Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 1/20 | 0.38 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.33 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.33 |
| ▸ | DAO | P14920 | 1/20 | 0.31 |
| ▸ | PDE2A | O00408 | 1/20 | 0.30 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.30 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.30 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | DPP4 | P27487 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18701033 | 0.85 | CYP1A2 (0.43) | IDO1EPHX2NR1H4DAOCYP1A2 | |
| SCHEMBL2600028 | 0.83 | IDO1 (0.54) | IDO1DAOPDE2ASLC6A2SLC6A4 | |
| SCHEMBL12775998 | 0.81 | IDO1 (0.38) | IDO1EPHX2NR1H4DAOPDE2A | |
| SCHEMBL1704764 | 0.76 | IDO1 (0.48) | IDO1DAO | |
| SCHEMBL855374 | 0.75 | TAAR1 (0.35) | CYP1A2DPP4 | |
| SCHEMBL17726213 | 0.75 | ADRA2B (0.45) | IDO1EPHX2NR1H4DPP4 | |
| SCHEMBL23790349 | 0.75 | ESR1 (0.43) | IDO1DPP4 | |
| SCHEMBL9917350 | 0.73 | HTR2A (0.39) | IDO1SLC6A2SLC6A4SLC6A3CYP1A2 | |
| SCHEMBL13020786 | 0.73 | PYCR1 (0.46) | — | |
| SCHEMBL18711204 | 0.72 | ESR1 (0.36) | PDE2ACYP1A2DPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220223796-A1 | ORGANIC COMPOUND, ELECTRONIC COMPONENT CONTAINING ORGANIC COMPOUND, AND ELECTRONIC DEVICE | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2022-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220223796-A1 | ORGANIC COMPOUND, ELECTRONIC COMPONENT CONTAINING ORGANIC COMPOUND, AND ELECTRONIC DEVICE | EXOC1, EXOC4, CHRM1 | IDO1 2126/4885EPHX2 412/4885NR1H4 4682/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.